Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 211 AL 225

The rhythm of decline: Circadian disruption in neurodegeneration

Singh J, Kumar D, Kaur J, Singh A.

J Food Drug Anal. 2025 Sep 18;33(3):224-240. doi: 10.38212/2224-6614.3553.

Photothermal nano-agents: an innovative trident weapon for accurate and effective treatment of alzheimer's disease

Chen J, Zhang X, Sun J, Zhi Y, Xie Z, Guan Y, Zhang Z, Wu C.

J Nanobiotechnology. 2025 Oct 10;23(1):650. doi: 10.1186/s12951-025-03709-z.

Tau-Targeted Therapeutic Strategies: Mechanistic Targets, Clinical Pipelines, and Analysis of Failures

Shen X, Li H, Zhang B, Li Y, Zhu Z.

Cells. 2025 Sep 26;14(19):1506. doi: 10.3390/cells14191506.

Targeting Oligodendrocyte Dysfunction in Alzheimer's Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists

Gurikar S, Ahmed SS, Raghunatahanaidu BD.

J Mol Neurosci. 2025 Oct 15;75(4):139. doi: 10.1007/s12031-025-02433-5.

Nutraceuticals intervention in Alzheimer's disease: From farm to pharma

Chaithra PM, Rakshith BS, Logesh S, Kanthesh BM, Gopenath TS, Chang HM, Perry G, Singh SK.

J Alzheimers Dis. 2025 Dec;108(3):969-996. doi: 10.1177/13872877251385216. Epub 2025 Oct 17.

Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation

Corbett A, Sultana J, Stych K, Mills R, Cummings JL, Williams G, Ismail Z, Soto-Martin M, Mintzer J, Gauthier S, Greig NH, Noble W, Killick R, Lai MKP, Routledge C, Walsh F, Fillit H, Aarsland D, Lane R, Mills K, Ballard C.

Alzheimers Res Ther. 2025 Nov 18;17(1):237. doi: 10.1186/s13195-025-01895-4.

The calpain-mediated proteolytic cleavage peptide P10 modulates Tau phosphorylation in Alzheimer's disease

Chinnathambi S, Dubey T, Rangappa N.

Adv Protein Chem Struct Biol. 2025;148:481-505. doi: 10.1016/bs.apcsb.2025.08.009. Epub 2025 Aug 30.

Precision therapeutics for Alzheimer's disease

Priyanka S, Manjari T, Hemalatha S, Ambika S, Yılmaz B, Aktürk B, Arısan ED, Kumari A, Manojkumar Y.

Prog Brain Res. 2025;297:247-276. doi: 10.1016/bs.pbr.2025.08.011. Epub 2025 Sep 11.

Alzheimer's Disease: The Current and Emerging Treatment Approaches

Pang R, Jia Q, Ma C, Li T, Bi W, Wang H, Liu R, Chen P, Lee ES, Jiang HB.

Behav Neurol. 2025 Dec 7;2025:9627699. doi: 10.1155/bn/9627699. eCollection 2025.

Can Beetroot (Beta vulgaris) Support Brain Health? A Perspective Review on Alzheimer's Disease

Kimble R, Shannon OM.

Nutrients. 2025 Dec 3;17(23):3790. doi: 10.3390/nu17233790.

Engineering exosomes for Alzheimer's disease: Multi-target therapeutic strategies from pathogenesis to clinical translation

Zhang Y, Li Z, Guan H, Qiu Z, Zou C.

Clin Transl Med. 2025 Dec;15(12):e70548. doi: 10.1002/ctm2.70548.

APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer's Disease and Cardiovascular Disease

Liu C, Liu J, Wang YY, Xu SF, Yu LM.

Mol Neurobiol. 2025 Dec 23;63(1):325. doi: 10.1007/s12035-025-05629-3.

The evolving landscape of Alzheimer's disease therapy: From Aβ to tau

Courade JP, Zetterberg H, Höglinger GU, Dewachter I.

Cell. 2025 Dec 24;188(26):7337-7354. doi: 10.1016/j.cell.2025.11.033.

Dendrimers: Patents for Alzheimer's Disease

Maheshwari S, Singh A.

Recent Pat Nanotechnol. 2025;19(3):356-363. doi: 10.2174/1872210517666230831154408.

Prospects of induced pluripotent stem cells in treating advancing Alzheimer's disease: A review

Park JJ, Rim YA, Sohn Y, Nam Y, Ju JH.

Histol Histopathol. 2025 Feb;40(2):157-170. doi: 10.14670/HH-18-766. Epub 2024 May 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias